What Happened With Shopify Stock?

Shopify Inc. (NYSE: SHOP) shares traded higher on Tuesday. The stock continued to rebound from recent losses and made a new high.

Shopify Inc. (NYSE:SHOP) shares traded higher on Tuesday. The stock continued to rebound from recent losses and made a new high. Here are the details.

What To Know: Shopify stock gained by over 3% despite any company-specific news behind the move.

Prior to Tuesday’s move, shares had sold off at the end of December and in the beginning of January after rising nearly 50% since October. The decline was largely driven by losses in the broader technology sector which were linked to a rise in Treasury yields.

However, as markets continued to look for direction on Tuesday, Shopify shares were able to move upward, pushing past their December high and marking a new 52-week high for the stock.

Additionally, over the past several weeks, Shopify stock has had its price target changed by several analysts, ranging from $65 to $100.

SHOP Price Action: Shares of Shopify closed Tuesday up 3.11% at $80.11, according to Benzinga Pro. 

Related Link: What’s Been Happening With Cytokinetics Stock?

Photo: 3D Animation Production Company from Pixabay

Total
0
Shares
Related Posts
Read More

Alexandria Real Estate Equities, Inc. Announces Accelerated Delivery Of Moderna’s New 462,100 RSF HQ And R&D Center, Designed To Be The Most Sustainable Laboratory Building In Cambridge, At 325 Binney Street On The One Kendall Square Mega Campus

Alexandria earned the 2023 Visionary Award from the Cambridge Chamber of Commerce for developing325 Binney Street, which will support Moderna as it advances a pipeline of mRNA medicines thatleverage its paradigm-shifting

ARE

Read More

Insmed Provides Business Update At 42nd Annual J.P. Morgan Healthcare Conference; Sees 2024 Global ARIKAYCE Revenues $340M-$360M; Delivers FY23 Revenues Exceeding The Upper End Of Guidance Range With Unaudited Global Net Product Sales Of ~$305.2M

—ARIKAYCE® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net Product Sales of Approximately $305.2 Million——2024 Global

INSM